tiprankstipranks
Advertisement
Advertisement

SE:SOBI Stock Latest News

Sobi Calls 2026 AGM With In-Person and Postal Voting Options
Company AnnouncementsSobi Calls 2026 AGM With In-Person and Postal Voting Options
16d ago
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 470 from SEK 395 at Barclays
2M ago
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
PremiumThe Fly
Swedish Orphan Biovitrum price target raised to SEK 500 from SEK 470 at Berenberg
2M ago
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
PremiumThe Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at Danske Bank
2M ago
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
PremiumCompany Announcements
Sobi Sets Ambitious 2030 Target to Double Revenue on Wave of New Rare-Disease Launches
2M ago
Swedish Orphan upgraded to Outperform from Underperform at BNP Paribas
PremiumThe FlySwedish Orphan upgraded to Outperform from Underperform at BNP Paribas
2M ago
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
Premium
Company Announcements
Sobi Posts Strong 2025 Growth and Expands Rare Disease Portfolio With Strategic Deals and Launches
2M ago
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Swedish Orphan Biovitrum Ab (0MTD) Q4 Earnings Cheat Sheet
2M ago
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
PremiumCompany Announcements
Sobi Lifts 2025 Revenue and Profitability Above Previous Outlook
3M ago
PremiumCompany Announcements
Sobi Advances Gamifant After Positive Phase 2a Data in Interferon-Gamma–Driven Sepsis
3M ago
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
PremiumCompany Announcements
Sobi Acquires Arthrosi Therapeutics to Strengthen Gout Treatment Pipeline
4M ago
Helena Saxon Resigns from Sobi Board of Directors
PremiumCompany Announcements
Helena Saxon Resigns from Sobi Board of Directors
6M ago
Sobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
PremiumCompany AnnouncementsSobi Reports Strong Q3 2025 Growth and Strategic Portfolio Expansion
6M ago
Sobi Revises 2025 Outlook Following Strong Q3 Performance
Premium
Company Announcements
Sobi Revises 2025 Outlook Following Strong Q3 Performance
6M ago
Sobi Increases Common Shares and Votes
Premium
Company Announcements
Sobi Increases Common Shares and Votes
6M ago
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
PremiumCompany Announcements
Sobi Announces Increase in Shares and Votes to Support Long-term Incentive Programs
8M ago
Sobi Completes Class C Share Issuance and Repurchase
PremiumCompany Announcements
Sobi Completes Class C Share Issuance and Repurchase
8M ago
Sobi Reports Strong Q2 2025 Growth and Pipeline Progress
PremiumCompany Announcements
Sobi Reports Strong Q2 2025 Growth and Pipeline Progress
9M ago
Sobi Board Approves Share Repurchase for Incentive Program
PremiumCompany Announcements
Sobi Board Approves Share Repurchase for Incentive Program
9M ago
0MTD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings0MTD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
Sobi and Apellis Amend Royalty Agreement for Aspaveli
Premium
Company Announcements
Sobi and Apellis Amend Royalty Agreement for Aspaveli
9M ago
Sobi’s Gamifant Receives FDA Approval for Treating MAS in Still’s Disease
Premium
Company Announcements
Sobi’s Gamifant Receives FDA Approval for Treating MAS in Still’s Disease
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >